Puregraf 75 IU Injection

What is Puregraf 75 IU Injection?

Puregraf 75 IU Injection is a medicinal product containing the active ingredient Menotrophin, produced by Gufic Biosciences Ltd. It is primarily used to assist women in overcoming infertility challenges. This injectable formulation is designed to stimulate ovarian follicle development, promoting ovulation in women who experience difficulty conceiving naturally. In Australia and other countries, Puregraf 75 IU Injection is recognized for its role in fertility treatments under medical supervision.

Uses of Puregraf 75 IU Injection

Puregraf 75 IU Injection is indicated for the treatment of female infertility, especially in cases of anovulation or oligoovulation, where the ovaries do not produce a mature egg monthly. It is often prescribed for women undergoing assisted reproductive technologies such as in vitro fertilization (IVF) or intrauterine insemination (IUI). Its use aims to increase the chances of conception by regulating and stimulating the female reproductive hormones.

How Puregraf 75 IU Injection Works

The injection contains Menotrophin, a combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones play a crucial role in the female reproductive cycle by promoting follicle growth and maturation in the ovaries. By administering Puregraf 75 IU Injection, the natural hormonal imbalance causing infertility is corrected, thus enhancing ovulation and improving fertility prospects.

Benefits of Puregraf 75 IU Injection

• Effective Ovulation Induction: Helps women with irregular or absent ovulation to produce mature eggs.
• Improved Fertility Outcomes: Increases the probability of conception when used alongside fertility treatments.
• Clinically Proven Formula: Contains pharmaceutical-grade Menotrophin ensuring consistent hormone levels.
• Trusted Manufacturer: Produced by Gufic Biosciences Ltd., known for quality and safety standards.
• Suitable for Multiple Regimens: Can be integrated with various assisted reproductive protocols.

Dosage and Administration

Dosage of Puregraf 75 IU Injection is carefully individualized based on patient response and physician guidance. Typically, treatment begins with a low dose, administered via subcutaneous or intramuscular injection, and adjusted according to ovarian response monitored through ultrasound and hormonal assays.

It is essential to administer the injection under medical supervision to reduce risks such as ovarian hyperstimulation syndrome. Patients are advised not to self-administer without proper training.

Available Strength

• Puregraf 150 IU Injection

Who Should Use Puregraf 75 IU Injection?

Women diagnosed with female infertility caused by anovulation or oligomenorrhea may benefit from this medication. It is suitable for those undergoing fertility treatments in Australia and globally, including women who have not responded adequately to oral ovulation-inducing agents.

Who Should Avoid Puregraf 75 IU Injection?

Puregraf 75 IU Injection should not be used by women with:

• Primary ovarian failure
• Uncontrolled thyroid or adrenal dysfunction
• Ovarian cysts unrelated to polycystic ovary syndrome
• Precancerous conditions or hormone-sensitive cancers
• Pregnancy or unexplained vaginal bleeding

Always inform your healthcare provider about your medical history prior to initiating therapy.

Possible Side Effects

While generally well tolerated, Puregraf 75 IU Injection may cause side effects including:

• Injection site reactions such as pain, redness, or swelling
• Headache or fatigue
• Bloating or abdominal discomfort
• Ovarian hyperstimulation syndrome (rare but serious)
• Multiple pregnancy (twins or more) due to overstimulation

Patients should report any severe or unusual symptoms immediately to their healthcare professional.

Safety Advice

Use Puregraf 75 IU Injection strictly as prescribed by your fertility specialist. Regular monitoring through blood tests and ultrasound is critical to ensure safety and efficacy. Avoid self-medication and never exceed recommended doses. Inform your doctor if you experience any adverse effects or if you have any allergies or pre-existing health conditions.

Drug Interactions

There are no well-documented interactions with other medicines; however, patients using hormonal therapies or medications affecting the reproductive system must inform their healthcare provider. Some fertility treatments may be combined for optimal outcomes, but only under medical supervision to prevent complications.

Storage Instructions

Store Puregraf 75 IU Injection in a cool, dry place between 2°C to 8°C (refrigerated). Do not freeze. Keep the injection vial in its original packaging to protect it from light. Keep out of reach of children and do not use after the expiration date.

Where to buy Puregraf 75 IU Injection?

Puregraf 75 IU Injection is available for purchase through licensed pharmacies ( kamagrajellyaustralia.com ) and authorized medical suppliers in Australia and other countries. Ensure that you obtain it through reputable sources to guarantee authenticity and safety. Consult your healthcare provider or fertility clinic for guidance on sourcing the medication.

Frequently Asked Questions (FAQ)

How long does it take for Puregraf 75 IU Injection to work?

Effectiveness usually becomes apparent within one or two treatment cycles, but response times vary depending on individual patient factors and dosage adjustments.

What should I do if Puregraf 75 IU Injection does not work?

If you do not respond as expected, consult your fertility specialist. They may modify your dose or recommend alternative therapies based on your ovarian response and health status.

Can I take Puregraf 75 IU Injection with other medicines?

Always inform your doctor about all medications you are taking. Combining fertility drugs may be necessary in some cases but should only be done under medical supervision.

Is Puregraf 75 IU Injection safe for older adults?

Safety and efficacy depend on individual health and reproductive status. Older women undergoing fertility treatment should be closely monitored by their healthcare provider.

What happens if I miss a dose?

Contact your healthcare provider immediately for instructions. Do not attempt to self-correct missed doses without professional advice.

Can side effects be prevented when using Puregraf 75 IU Injection?

Regular monitoring and following prescribed dosages minimize the risk of side effects. Notify your doctor immediately if you experience any unusual symptoms.

When should I avoid using Puregraf 75 IU Injection?

Avoid use if you have known contraindications such as ovarian cysts, hormone-sensitive cancers, or if you are pregnant. Discuss all conditions with your physician before starting treatment.

Conclusion

Puregraf 75 IU Injection offers an effective and trusted pharmaceutical option for women facing infertility challenges related to ovulation issues. Manufactured by Gufic Biosciences Ltd., this hormone-based therapy supports ovarian follicle development under professional medical guidance. Proper use, monitoring, and consultation with healthcare providers ensure optimal safety and effectiveness in fertility management.